FGF23 is a bone-derived hormone that regulates systemic phosphate homeostasis, vitamin
D metabolism and α-Klotho expression through a novel bone-kidney axis. FGF23 inhibits …

The discovery of fibroblast growth factor 23 (FGF-23) has expanded our understanding of
phosphate and vitamin D homeostasis and provided new insights into the pathogenesis of …

Introdução: Dados nacionais sobre diálise crônica têm tido impacto no planejamento do
tratamento. Objetivo: Apresentar dados do inquérito da Sociedade Brasileira de Nefrologia …

BACKGROUND: Abnormalities in serum calcium, phosphorus, and parathyroid hormone
(PTH) concentrations are common in patients with chronic kidney disease and have been …

Although renal osteodystrophy and vitamin D analogs may be related to survival in
maintenance hemodialysis (MHD) patients, most studies have examined associations …

The risk of death in hemodialysis patients treated with calcium-containing phosphate
binders or sevelamer is not known. We assessed all-cause mortality in 127 patients new to …

Background Abnormalities in serum phosphorus, calcium and parathyroid hormone (PTH)
have been associated with poor survival in haemodialysis patients. This COSMOS (Current …

Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-
related quality of life in secondary hyperparathyroidism. Background Secondary …

Intravenous vitamin D is standard therapy for secondary hyperparathyroidism in
hemodialysis (HD) patients. In for-profit dialysis clinics, mortality was higher for patients on …

Abstract Background. Dialysis Outcomes and Practice Patterns Study has shown that the
proportion of haemodialysis patients with adequate mineral metabolism parameters …